Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/2009
03/05/2009WO2009029770A1 Enhancement of transgene expression from viral-based vaccine vecors by expression of suppressors of the type i interferon response
03/05/2009WO2009028663A1 Anti-claudin-3 antibody
03/05/2009WO2009028662A1 Detection of bacterium belonging to genus campylobacter which targets cytolethal distending toxin
03/05/2009WO2009028639A1 Anti-epha2 antibody
03/05/2009WO2009028575A1 Activator for blood coagulation factor vii promoter and utilization of the same
03/05/2009WO2009028531A1 Docrine polypeptide and method of purifying recombinant fused protein using the same
03/05/2009WO2009028253A1 Peptide production method
03/05/2009WO2009027752A2 Process for producing hepcidin
03/05/2009WO2009027041A1 Glycosylation profile analysis
03/05/2009WO2009026716A1 Method for cellulase production
03/05/2009WO2009026692A1 An anti-cancer cytotoxic monoclonal antibody
03/05/2009WO2008156704A3 Antibody-mediated modulation of allergy
03/05/2009WO2008153903A3 Heterologous and homologous cellulase expression system
03/05/2009WO2008141795A3 Cell-free protein synthesis of deuterated proteins for structural and functional studies by nmr spectroscopy
03/05/2009WO2005094355A3 Methods for altering protein production rates
03/05/2009WO2005079300A9 Protein kinase inhibitors and methods for identifying same
03/05/2009US20090064351 Transgenic bird producing erythropoietin and method of constructing the same
03/05/2009US20090062510 Human Chemotactic Cytokine I Polypeptides
03/05/2009US20090062188 Disease-Associated Protein
03/05/2009US20090062181 Mineral Collagen Chelates And Methods Of Making And Using Same
03/05/2009US20090062139 Phytases, nucleic acids encoding them and methods for making and using them
03/05/2009US20090061511 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics
03/05/2009US20090061485 Method of Producing an Antibody Using a Cell in Which the Function of Fucose Transporter Is Inhibited
03/05/2009US20090061484 Enzymatic hydrolysis of lignocellulosic feedstocks using accessory enzymes
03/05/2009US20090061483 Acid fungal proteases
03/05/2009US20090061482 Nucleotide sequences of coryneform bacteria coded for proteins participating in l-serine metabolism and method for microbial production of l-serine
03/05/2009US20090061481 Highly-efficient hyperthermophilic dna ligase
03/05/2009US20090061480 Nucleotide sequence encoding a modulator of nf-kb
03/05/2009US20090061458 Heterooligomeric Taste Receptor
03/05/2009US20090061444 Phytochrome-based fluorophores
03/05/2009US20090060952 Production of the lipidated form of the peptidoglycan-associated liproproteins of gram-negative bacteria
03/05/2009US20090060948 Cationic lipid-mediated enhancement of nucleic acid immunization of cats
03/05/2009US20090060935 Amebiasis vaccine
03/05/2009US20090060930 Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes
03/05/2009US20090060919 BINDING MEMBERS FOR IgE MOLECULES
03/05/2009US20090060916 Ligands that bind IL-4 and/or IL-13
03/05/2009US20090060914 Deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection
03/05/2009US20090060909 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability
03/05/2009US20090060907 Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3
03/05/2009US20090060865 Mammalian receptor proteins; related reagents and methods
03/05/2009DE102007041735A1 Use of a multi-functional active substance mixture comprising a peptide fraction and an amino acid fraction, for producing a formulation for regulating the outer skin conditions of mammals including humans
03/05/2009CA2698146A1 Anti-epha2 antibody
03/05/2009CA2697976A1 A process for producing a peptide hormone
03/05/2009CA2697480A1 Detection of bacteria belonging to the genus campylobacter by targeting cytolethal distending toxin
03/05/2009CA2697091A1 Glycosylation profile analysis
03/05/2009CA2685714A1 Inducible mutagenesis of target genes
03/04/2009EP2031066A1 Mutant and gene encoding the same
03/04/2009EP2030986A1 Polypeptide derivative of parathyroid hormone (PTH)
03/04/2009EP2029764A2 In vitro protein expression process comprising c fusion molecules
03/04/2009EP1899476A4 Production of cellulase
03/04/2009EP1608748B1 Ligational encoding of small molecules
03/04/2009EP1414494B1 Inhibitory antibodies of her3 activity
03/04/2009EP1246917B1 Human stra6 polypeptides
03/04/2009EP1176210B1 Preparation containing cell extract for synthesizing cell-free protein and means for synthesizing cell-free protein
03/04/2009EP1078006B1 Diagnosis and treatment of hepatic disorders
03/04/2009CN101379184A Novel oxidoreductases and uses thereof
03/04/2009CN101376888A Method for producing secretion expression recombinant human fibroblast growth factor-21
03/04/2009CN100465285C An extracting method of carnosine
03/04/2009CN100465284C Functional mixed short peptide of peanuts, and a preparation method thereof
03/04/2009CN100464639C A composition with heart rate reducing property
03/03/2009US7498424 Bioassy for identifying compounds which prevent host proteins interation with viral protein associated with infection, replication, assembly or release; viricides
03/03/2009US7498421 Antibody specific for 4-methyl-3-vinylmaleimide derivatives; photolabile degradation product of bilirubin or biliverdin; antiinflammatory agents, infections,systemic inflammatory response syndrome
03/03/2009US7498417 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy
03/03/2009US7498415 Culturing, gene expression, transformation; fab and fv fragments; biodrugs; anticarcinogenic agents, diabetes, acromegaly
03/03/2009US7498411 P49/STRAP is a novel protein involved in gene regulation and cell proliferation
03/03/2009US7498314 Expression vectors and uses thereof
03/03/2009US7498306 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents
03/03/2009US7498305 Activated protein C variants with normal cytoprotective activity but reduced anticoagulant activity
03/03/2009US7498165 Rapidly cleavable SUMO fusion protein expression system for difficult to express proteins
03/03/2009US7498159 Transgenic fungal strain for use as bioreactor in synthesis of glucoamylase; ethanol fermentation
03/03/2009US7498158 Termamyl-like alpha-amylase for starch conversion, ethanol, laundry, dish, hard surface cleaning, textile desizing and/or sweetner production
03/03/2009US7498155 Providing a bacterium such as Geobacteraceae expressing a conductive proteinaceous pilus; culturing in medium containing an electron acceptor such as iron III oxide; coupling to circuit; self-assembling; no need for metallization
03/03/2009US7498154 Nucleotide sequences coding cytokine receptor for identifying modulators for prevention and treatment of infection, cell proliferative and autoimmune disorders
03/03/2009US7498153 Chimeric immunogens
03/03/2009US7498152 Interferon-alpha polypeptides and conjugates
03/03/2009US7498151 Variant TLR4 nucleic acid and uses thereof
03/03/2009US7498150 Materials and methods to increase peptide chain expression
03/03/2009US7498149 Proteins having effects of controlling cell migration and cell death
03/03/2009US7498148 A site specific clostripain cleavage of single and multicopy polypeptides ( glucagon-like peptide)
03/03/2009US7498143 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
03/03/2009US7498139 Using presence of procalcitonin or procalcitonin partial peptides to detect septicemia; determining proprotein concentrations in sample
03/03/2009US7498129 Measuring changes in level of antigen recognizable by a monoclonal antibody or antigen binding fragment; monoclonal antibody is produced by hybridoma cell line; decreased level indicates a reduced tumor; diagnosis, cell purification
03/03/2009US7498127 Drug screening for cytostatic agent intracellular signaling inhibitor such as antitumor agents, antirheumatic agents; cardiovascular disorders; producing within a cell a fragment of heparin binding-epidermal growth factor (HB-EGF); determination of nuclear export of PLZF protein
03/03/2009US7498034 Imaging, diagnosis and treatment of disease
03/03/2009US7498032 Methods for treating immune disorders or cancer with anti-CD40 antibodies
03/03/2009US7498029 Photoimmunotherapies for cancer using combination therapies
03/03/2009US7498024 Expression vector comprising nucleotide sequences coding foot and mouth viral, as well as, immunoglobulin sequences for use in generation imunotherapeutics
03/03/2009CA2276108C Novel peptide, novel dna, and novel antibody
03/03/2009CA2238278C Antigenic protein originating in malassezia
02/2009
02/26/2009WO2009026456A2 Poxvirus methods and compositions
02/26/2009WO2009026393A2 Amino acid substituted molecules
02/26/2009WO2009026338A1 Intracellular reporters
02/26/2009WO2009026177A1 Psma binding ligand-linker conjugates and methods for using
02/26/2009WO2009026131A2 Vectors and methods for improved expression of eukaryotic proteins in bacteria
02/26/2009WO2009025300A1 Peptide capable of binding to immunoglobulin
02/26/2009WO2009025196A1 Foxm1 peptide and medicinal agent comprising the same
02/26/2009WO2009025080A1 Colorectal cancer marker polypeptide, and method for diagnosis of colorectal cancer
02/26/2009WO2009023961A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease
02/26/2009WO2009023955A1 Cytotoxicity mediation of cells evidencing surface expression of cd9
02/26/2009WO2008157379A3 Covalent diabodies and uses thereof